Sara Elgott

OpalMedica

Managing Director

OpalMedica is a MedTech company developing two complementary solutions to accelerate earlier detection of rare and underdiagnosed conditions: KLEOS™ Clinical Flags, a patent-pending Class I medical device, which helps GPs identify potential cases sooner by prompting consideration of rare conditions; and KLEOS™ My Rare Journey, a patient platform for sharing experiences and insights. Together, they inform research and improve outcomes.

Life Science Integrates
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.